Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
08:07am, Wednesday, Aug 13, 2025
Aura Biosciences, Inc. (NASDAQ: AURA) - What's happening inside
Short version: the company accelerated clinical and manufacturing work on its lead VDC candidate belzupacap sarotalocan (bel‑sar), funded that activity with a May 16, 2025 follow‑on offering, and materially increased its cash and equ...
08:06am, Wednesday, Aug 13, 2025
Sagimet Biosciences Inc. (NASDAQ: SGMT) - quick operating & financial snapshot
What's happening inside: management is funding aggressive clinical progression - denifanstat advancing toward Phase 3 (positive Phase 2b data and FDA Breakthrough Therapy designation) while a China partner (Ascletis) r...
08:05am, Wednesday, Aug 13, 2025
Company: SideChannel, Inc. (OTCBB: CLOK)
Quick summary - what's happening inside
* Management is pushing Enclave adoption and expanding cybersecurity services while ramping selling & marketing headcount and RSU-based compensation to retain employees.
* The company issued 4,897,323 shares when RS...
08:05am, Wednesday, Aug 13, 2025
Quick take - Tourmaline Bio, Inc. (NASDAQ: TALS)
What's happening inside: management is ramping clinical activity and spending to advance pacibekitug (IL‑6 inhibitor) across cardiovascular inflammation (TRANQUILITY), thyroid eye disease (spiriTED) and a planned AAA Phase 2. The company reported p...
08:04am, Wednesday, Aug 13, 2025
XOMA Royalty Corporation (NASDAQ: XOMA) - Quick take
What's happening inside: XOMA is executing its royalty-aggregator strategy - buying royalty/milestone streams and making targeted acquisitions (BioInvent, Castle Creek, Pulmokine) while monetizing select Kinnate assets. The company is generatin...
08:03am, Wednesday, Aug 13, 2025
Adaptimmune Therapeutics plc (NASDAQ: ADAP) - Snapshot
Adaptimmune reported Q2 2025 operating results and then executed a major corporate transaction in late July 2025. The company sold its cell‑therapy commercial and late‑stage assets (including TECELRA and lete‑cel) to US WorldMeds, received $5...
08:02am, Wednesday, Aug 13, 2025
DUKE Robotics Corp. (PINK: USDR) - Quick read on what's happening inside
Source: Form 10-Q for quarter ended June 30, 2025. All amounts in USD thousands unless noted.
Key facts & figures
- Revenues (3 months ended 6/30/2025): $143
- Cost of revenues (3 months): $55 - Gross profit (3 months): $88
...
08:01am, Wednesday, Aug 13, 2025
Wilhelmina International, Inc. (NASDAQ: WHLM) - Q2 2025 snapshot
Quick read: revenue growth on a six‑month basis and rising gross billings, but profitability and operating margins compressed in Q2 as personnel and office costs rose; cash fell and receivables increased. Management executed a $0.8...
07:04am, Wednesday, Aug 13, 2025
Xenous Holdings, Inc. (PINK: XITO) - Quarterly snapshot (period ended June 30, 2025)
Short take: Xenous is a non‑operating shell with no revenue, zero cash, and ongoing reliance on advances from its majority shareholder while it completes due diligence on a proposed Malaysia acquisition. Results ...
07:03am, Wednesday, Aug 13, 2025
Quick take - China Automotive Systems, Inc. (NASDAQ: CAAS)
Inside the company: sales are growing and cashflow improved materially in H1 2025 while the business shifts toward electric power steering (EPS). Management is investing more in R&D and completing organizational moves (a proposed redomici...
07:02am, Wednesday, Aug 13, 2025
GivBux, Inc (PINK: GBUX) - quick operating and income-statement snapshot.
Headline summary
GivBux reported revenue growth year-over-year but recorded very large non‑cash losses that drove a steep net loss and widened stockholders' deficit. The company flagged a going concern and material internal...
07:01am, Wednesday, Aug 13, 2025
Snapshot - HG Holdings, Inc. (NASDAQ: STLY)
Straightforward: Q2 2025 showed revenue and profitability improvement driven by higher title volumes and new related‑party management fees, but the company remains small, highly connected to related parties and dependent on non‑cash transactions and equ...
07:01am, Wednesday, Aug 13, 2025
ESSA Pharma Inc. (NASDAQ: EPIX) - Snapshot
What's happening inside the company: ESSA has effectively moved from active clinical development into a wind‑down and strategic exit process. The firm terminated its masofaniten (EPI‑7386) clinical program (announced Oct 31, 2024), is winding down precli...
06:26pm, Tuesday, Aug 12, 2025
Ascent Solar Technologies, Inc. (NASDAQ: ASTI) - What's happening inside
Short version: revenue remains tiny and roughly flat year‑over‑year, the company is cutting some operating costs but increasing R&D and equity compensation, continues to burn cash (~$3.36M YTD), has raised capital via ATM an...
06:25pm, Tuesday, Aug 12, 2025
CO2 Energy Transition Corp. (NASDAQ: NOEMU) - Quick take
This is a blank‑check (SPAC) that closed its IPO on November 22, 2024 and sits largely in a trust account waiting to complete a business combination. The company reported net income for Q2 2025 driven entirely by interest on trust assets, w...